This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Voronoi Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Soo Chan Kim
Introduction
Soo Chan Kim is a prominent inventor based in Gyeonggi do, South Korea. He has made significant strides in the field of pharmaceuticals, particularly in the development of treatments for inflammatory diseases. His work is characterized by a commitment to innovation and a focus on improving health outcomes.
Latest Patents
Soo Chan Kim holds a patent for the use of pyrrolopyridine derivatives in preventing or treating inflammatory diseases. The patent describes a pharmaceutical composition that includes a pyrrolopyridine-derivative compound as an active ingredient. This compound, represented by Chemical Formula 1, exhibits excellent inhibitory activity against protein kinases, inflammatory factors, and cytokines. The composition is particularly useful for the prevention and treatment of inflammatory bowel disease, rheumatoid arthritis, and lupus.
Career Highlights
Throughout his career, Soo Chan Kim has been associated with Voronoi Co., Ltd., where he has contributed to various innovative projects. His expertise in pharmaceutical development has positioned him as a key figure in the industry. His dedication to research and development has led to advancements that benefit patients suffering from inflammatory conditions.
Collaborations
Soo Chan Kim has collaborated with notable colleagues, including Dae Kwon Kim and Dong Hyuk Seo. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their work.
Conclusion
Soo Chan Kim's contributions to the field of pharmaceuticals, particularly through his innovative patent, highlight his role as a leading inventor in the treatment of inflammatory diseases. His work continues to inspire advancements in medical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile